SCHEMBL27135495

SCHEMBL27135495

Nc1cc(C(=O)O)ccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 2/20 0.41
▸ TBK1 Q9UHD2 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ CSNK2A2 P19784 6/20 0.38
▸ CSNK2A1 P68400 6/20 0.38
▸ KDR P35968 1/20 0.38
▸ SCD O00767 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ PRSS12 P56730 2/20 0.36
▸ POLQ O75417 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24072414 0.85 CSNK2A2 (0.41) IKBKETBK1CSNK2A2CSNK2A1KDR
SCHEMBL25063293 0.83 PRSS12 (0.41) KDM4EMAPTCSNK2A2CSNK2A1ALDH1A1
SCHEMBL25063129 0.82 CSNK2A2 (0.53) CSNK2A2CSNK2A1KDRSCDNPC1
SCHEMBL24074140 0.81 NPC1 (0.56) KDM4EMAPTKDRALDH1A1NPC1
SCHEMBL24072749 0.80 STAT3 (0.41) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL29056990 0.79 STAT3 (0.59) MAPTTHRBRECQLALDH1A1NPC1
SCHEMBL30339343 0.79 STAT3 (0.59) MAPTTHRBRECQLALDH1A1NPC1
SCHEMBL27135218 0.77 CYP1A2 (0.55) KDM4EMAPTKDRSCDALDH1A1
SCHEMBL25063447 0.77 RAB9A (0.41) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL24073708 0.75 KDR (0.64) KDM4ECSNK2A2CSNK2A1KDRSCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 IKBKE 1854/4885TBK1 1684/4885KDM4E 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback